Showing 5751-5760 of 8818 results for "".
- Oculus Innovative Sciences Receives FDA Approval for Post-Dermal-Procedures Producthttps://practicaldermatology.com/news/oculus-innovative-sciences-receives-fda-approval-for-post-dermal-procedures-product/2458455/The FDA awarded Oculus Innovative Sciences, Inc. 510(k) clearance for its new post-dermal-procedures product. Under the supervision of a healthcare professional, the product is intended for the removal of foreign material including microogranisms and debris from postdermal procedures. <
- It's So Far, So Good for BioPharmX's New Acne Drughttps://practicaldermatology.com/news/its-so-far-so-good-for-biopharmxs-new-acne-drug/2458458/BioPharmX Corporation’s novel topical minocycline, BPX-01, reduced facial P. acnes by more than 90 percent after four weeks, new research shows. In the Phase 2a study, a daily 10 mg dose of topical minocycline offered P. acnes r
- Face-Aging App May Encourage Sun-Safe Behaviorhttps://practicaldermatology.com/news/face-aging-app-may-encourage-sun-safe-behavior/2458460/Appealing to their vanity may be the best way to encourage young women to practice sun-safe behaviors, a new study shows. The new research, published in
- Fat Chance Teen Acne Doesn't Contain Diacylglycerolshttps://practicaldermatology.com/news/study-fat-chance-teen-acne-doesnt-contain-diacylglycerols/2458462/New research provides a fingerprint of the fats found in sebum, namely diacylglycerols. The findings appear in the Journal of Lipid Resea
- Merz Acquires Aesthetics Medical Device Company ON Light Scienceshttps://practicaldermatology.com/news/merz-acquires-aesthetics-medical-device-company-on-light-sciences/2458463/With its newest acquisition of ON Light Sciences, Inc., Merz North America is expanding their reach into the laser-adjacent dermatologic arena. ON Light Sciences, Inc. is a U.S. medical device company developing technologies to en
- Paratek Initiates Phase 3 Study of Oral Omadacycline for MRSA, Acute Skin Infectionshttps://practicaldermatology.com/news/paratek-initiates-phase-3-study-of-oral-omadacycline-for-mrsa-acute-skin-infections/2458465/The first patient has been dosed in Paratek Pharmaceuticals, Inc.’s second pivotal Phase 3 study of omadacycline for acute bacterial skin and skin structure infections (ABSSSI). Omadacycline is a new once-daily oral and IV, well-tolerated
- Skin Cancer Foundation Calls for Grant Proposals for the 2017 Research Grant Awards Programhttps://practicaldermatology.com/news/skin-cancer-foundation-calls-for-grant-proposals-for-the-2017-research-grant-awards-program/2458466/The Skin Cancer Foundation is calling for grant proposals for their 2017 Research Grant Awards Program. Four grants of $25,000 will be awarded to research projects and clinical studies related t
- Valeant Dermatology ASPIRE HIGHER Scholarship Program Names Winnershttps://practicaldermatology.com/news/valeant-dermatology-aspire-higher-scholarship-program-names-winners/2458472/Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, announced the winners of its ASPIRE HIGHER Scholarship Program. Nine undergraduate and graduate students were selected from a pool of 970 applicants and awarded up to $10,000 each tow
- BEVL Blasts Off: New Mobile Network Seeks to Connect Aesthetic Proshttps://practicaldermatology.com/news/bevl-blasts-off-new-mobile-network-seeks-to-connect-aesthetic-pros/2458474/Meet BEVL, a new mobile network that connects medical aesthetics professionals. In private beta testing since June, BEVL is now accessible via iOS, Android and th
- Skinbetter scienceTM Debuts with Launch of New Anti-aging Productshttps://practicaldermatology.com/news/skinbetter-sciencetm-debuts-with-launch-of-new-anti-aging-products/2458478/Introducing skinbetter scienceTM ... the brainchild of Jonah Shacknai and several former members of the Medicis leadership team among others. The new line will debut in physician offices nationwide in August 2016. The